Today we were notified that Daniela has been named a Newton Advanced Fellow by the Academy of Medical Sciences and the Royal Society of the UK! This Fellowship has been awarded to investigate the genetic susceptibility to acral lentiginous melanoma through population studies and the use of statistical genomics methodologies. Our partner in this project is Prof. Tim Bishop, Professor of Genetic Epidemiology and Director of the Leeds Institute of Cancer and Pathology. We are very excited as this project will allow students in the lab to undertake training in statistics and genetic epidemiology while exploring the genetics of acral lentiginous melanoma.
We are thrilled to announce we’ve been awarded a grant, part of the Cancer Research and Global Health Initiative of the Medical Research Council (UK), to study potential drug targets of acral lentiginous melanoma (ALM) in Latin American patients. This proposal is also co-led by Dr David Adams (Sanger Institute, UK) and Dr Patricia Possik (Brazilian National Cancer Institute [INCA], Brazil), with the support of Prof Meenhard Herlyn (Wistar Institute, USA) and Dr. Hector Martinez-Said (Mexican National Cancer Institute, Mexico). This award will fund our research into animal models and potential drug targets of ALM for the next two years, and will officially start our collaborations with INCA. We’re very thankful to the MRC for this funding, and can’t wait to get to work!
This award, given by the University of California Institute for Mexico and the United States (UC MEXUS) and the National Council for Research and Technology of Mexico (CONACYT) is intended to help establish long-lasting collaborations between scientists based in University of California campuses and in Mexican institutions.
In this spirit, we are thrilled to be starting a formal collaboration with Prof. Ludmil Alexandrov, of the University of California, San Diego – widely recognised as the founder of the field of mutational signatures in cancer. This Award will allow PhD students from both groups to undertake reciprocal research internships to train in different specialised bioinformatic techniques (UCSD lab: Mutational signature analysis, UNAM lab: causal germline variant prioritisation), project planning meetings, as well as providing funds for expanding our institutional computer cluster and for performing bench experiments for hypothesis testing.
Kudos to Caro Castañeda, the PhD student in our lab who will be leading this collaboration from our side! Loads of exciting science to come 🙂
We are deeply thankful to UC MEXUS and CONACYT for this opportunity, and can’t wait to see what the results will be!